How Common is Major Hemorrhage in Veterans With CLL?

COLUMBIA, SC – Noting that chronic lymphocytic leukemia (CLL) patients are at increased risk for major hemorrhage (MH), a new study reported incidence of MH in veterans with CLL, as well as risk factors. The study, published in Cancer Medicine, was conducted before...

DOAC Uses Rapidly Expand

Dabigatran, apixaban, edoxaban and rivaroxaban all have FDA approval for use to reduce the risk of stroke and blood clots in patients with nonvalvular atrial fibrillation and treatment of deep vein thrombosis and pulmonary embolism. Dabigatran, apixaban and rivaroxaban are also indicated for the prevention of blood clots after hip or knee replacement surgery.

VAMCs Continue to Lag in HCP Flu Vaccine Mandates

ANN ARBOR, MI—The VA continues to lag behind community hospitals in mandating annual influenza vaccine for all healthcare personal, a new study suggested. The report in JAMA Network Open said requiring HCP vaccination against the flu helps limit disease spread to...

Executive Order Enlists DoD Help in Modernizing Flu Vaccine

WASHINGTON—A new executive order is aimed at increasing the manufacturing efficiency and effectiveness of flu vaccines. The DoD and Department of Health and Human Services are co-chairing a task force in the process of implementing the order signed in September by...

Respirators No More Effective Than Masks in Flu Prevention

PITTSBURGH—How effective are N95 respirators and medical masks in preventing healthcare personnel from acquiring workplace viral respiratory infections? A study in JAMA sought to answer that question. Researchers from the National Personal Protective Technology...

Successful PTSD Treatment Halves Diabetes Risk for Veterans

LOUIS—Improving post-traumatic stress disorder symptoms, a laudable goal itself, has the added benefit of lowering patients’ risk for developing Type 2 diabetes, according to a new report. A cohort study by Jeffrey Scherrer, PhD, professor of family and community...

Testosterone Therapy Increases PSA in 5% of Older Users

HOUSTON – How does testosterone treatment of older hypogonadal men affect prostate specific antigen (PSA) changes? That is the question raised by a study published in the Journal of Clinical Endocrinology & Metabolism. Baylor College of Medicine researchers and...

PSA Bounce Affects Races Differently in Prostate Cancer

RICHMOND, VA -- African American men have historically had poorer prostate cancer biochemical and survival outcomes than Caucasians. The question is why? So asked a new study suggesting that emerging data point to nononcologic factors for much of this disparity. The...

U.S. Medicine Archives

U.S. Medicine Supplements

CE Credits